MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry

NCT ID: NCT06455488

Last Updated: 2024-06-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

130 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-20

Study Completion Date

2030-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Data collection registry for patients with ventricular tachycardia to help physicians give better care for patients clinically and procedurally.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After consent from a patient the research team will input patients data from many different categories. There is a link to the PDF for the consent form, a patients anticoagulant medications will be assessed, their ventricular tachycardia (VT) history will be inputted, and their date of birth and zip code will inputted. The research team will then input any EKG's, echocardiograms, VT ablations, ICD's, S-ICD's, lab results, and comorbidities.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ventricular Tachycardia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MANAGE-VT Patients

Patients will be assessed on the status of their ventricular tachycardia as well as other criteria such as: EKG,

Ventricular Tachycardia Ablation

Intervention Type PROCEDURE

This is a surgical ablation meant to reset patients irregular rhythm back to sinus.

ICD Implant

Intervention Type DEVICE

A pacemaker or defibrillator implant to prevent SCD

Antiarrhythmic drug

Intervention Type DRUG

Drug therapies

EKG

Intervention Type DIAGNOSTIC_TEST

Monitoring EKG testing done on registry patients

Cardioversion

Intervention Type DIAGNOSTIC_TEST

Monitoring cardioversions on registry patients

Echocardiogram

Intervention Type DIAGNOSTIC_TEST

Monitoring echocardiogram testing done on patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ventricular Tachycardia Ablation

This is a surgical ablation meant to reset patients irregular rhythm back to sinus.

Intervention Type PROCEDURE

ICD Implant

A pacemaker or defibrillator implant to prevent SCD

Intervention Type DEVICE

Antiarrhythmic drug

Drug therapies

Intervention Type DRUG

EKG

Monitoring EKG testing done on registry patients

Intervention Type DIAGNOSTIC_TEST

Cardioversion

Monitoring cardioversions on registry patients

Intervention Type DIAGNOSTIC_TEST

Echocardiogram

Monitoring echocardiogram testing done on patients

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Pacemaker Implant Statin Therapy Anticoagulants

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must be at least 18 years old
* Must not be

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CorVita Science Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Corvita Science Foundation

Chicago, Illinois, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Martin C Burke, DO

Role: CONTACT

7735208322

Edward M Burke

Role: CONTACT

7737297956

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Martin C Burke, DO

Role: primary

773-520-8322

Edward M Burke

Role: backup

7737297956

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-CSF-00300

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Corheart 6: Long-term Cohort Study
NCT07094919 RECRUITING NA
Heart Sounds Registry
NCT03203629 COMPLETED